Bevacizumab injection for epistaxis in hereditary hemorrhagic telangiectasia

被引:0
|
作者
Casady, Megan [1 ]
Burton, Claude [1 ]
机构
[1] Duke Univ, Dept Dermatol, Durham, NC 27706 USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
4616
引用
收藏
页码:AB55 / AB55
页数:1
相关论文
共 50 条
  • [1] Is Bevacizumab Effective for Reducing Epistaxis in Hereditary Hemorrhagic Telangiectasia?
    Chin, Christopher J.
    [J]. LARYNGOSCOPE, 2017, 127 (02): : 289 - 290
  • [2] The Effect of Bevacizumab (Avastin) Treatment on Epistaxis in Hereditary Hemorrhagic Telangiectasia
    Simonds, Jana
    Miller, Frank
    Mandel, Jess
    Davidson, Terence M.
    [J]. LARYNGOSCOPE, 2009, 119 (05): : 988 - 992
  • [3] Bevacizumab as Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Literature Review
    Kini, Sameer D.
    Yiu, Daniel W.
    Weisberg, Reid A.
    Davila, Juan F.
    Chelius, Daniel C.
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2019, 128 (05): : 467 - 471
  • [4] Bevacizumab pharmacokinetics influences cardiac index and epistaxis in hereditary hemorrhagic telangiectasia
    Azzopardi, N.
    Dupuis-Girod, S.
    Ternant, D.
    Fargeton, A. E.
    Bailly, S.
    Paintaud, G.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 75 - 75
  • [5] Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia
    Parambil, Joseph G.
    Woodard, Troy D.
    Koc, Omer N.
    [J]. LARYNGOSCOPE, 2018, 128 (10): : 2234 - 2236
  • [6] Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia: An Evidence-based Review
    Halderman, Ashleigh A.
    Ryan, Matthew W.
    Marple, Bradley F.
    Sindwani, Raj
    Reh, Douglas D.
    Poetker, David M.
    [J]. AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2018, 32 (04) : 258 - 268
  • [7] Tranexamic Acid and Bevacizumab in Hereditary Hemorrhagic Telangiectasia Patients Presenting With Epistaxis
    Lacout, Alexis
    Marcy, Pierre-Yves
    El Hajjam, Mostafa
    Lacombe, Pascal
    [J]. CUTIS, 2013, 91 (04): : 173 - 174
  • [8] Injection of bevacizumab and cyanoacrylate glue for hereditary hemorrhagic telangiectasia
    Khoueir, Nadim
    Borsik, Michel
    Camous, Domitille
    Herman, Philippe
    Verillaud, Benjamin
    [J]. LARYNGOSCOPE, 2019, 129 (10): : 2210 - 2215
  • [9] Cauterization for epistaxis in hereditary hemorrhagic telangiectasia
    Dabiri, J.
    Fakhoury, R.
    Choufani, G.
    Mine, B.
    Hassid, S.
    [J]. B-ENT, 2016, 12 (01): : 9 - 16
  • [10] EPISTAXIS DUE TO HEREDITARY HEMORRHAGIC TELANGIECTASIA
    ZOHAR, Y
    STRAUSS, M
    [J]. LARYNGOSCOPE, 1995, 105 (04): : 445 - 446